RIGL
RIGEL PHARMACEUTICALS INC
Nasdaq Pharmaceutical Preparations Accelerated filer

Key Financials

Gross Profit
$17.4M
↑ 7.9%
Total Assets
$513.6M
↑ 213.2%
EPS (Diluted)
$19.48
↑ 1867.7%
Total Liabilities
$122.1M
↓ 24.0%
Revenue
$294.3M
↑ 64.1%
Net Income
$367.0M
↑ 1999.1%
Shareholders' Equity
$391.5M
↑ 11806.3%
Cash & Equivalents
$40.6M
↓ 28.5%

Recent SEC Filings

Form Type Filed Date Link
8-K 7/1/2026 View on SEC
4 6/24/2026 View on SEC
4 6/22/2026 View on SEC
4 6/22/2026 View on SEC
4 6/22/2026 View on SEC
4 6/22/2026 View on SEC
4 6/22/2026 View on SEC
144 6/22/2026 View on SEC
8-K 6/17/2026 View on SEC
4 6/3/2026 View on SEC

Company Information

Field Value
Ticker RIGL
Company Name RIGEL PHARMACEUTICALS INC
CIK 1034842
Sector Pharmaceutical Preparations
Industry Accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 650-624-1100